Search research articles
Contact Us
Filters
Showing results (311-320 of 364) with videos related to
Page
of 37
Sort By:
Wiener Klinische Wochenschrift
|
December 13, 1996
[Creutzfeldt-Jakob disease in Austria]
J A Hainfellner, K Jellinger, H Diringer, et al.
Advances in Neurology
|
January 1, 1983
Combination treatment with selective monoamine oxidase inhibitors and dopaminergic agonists in Parkinson's disease: biochemical and clinical observations
P Riederer, K Jellinger, W Danielczyk, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 1, 1997
Iron in the Parkinsonian substantia nigra
M Gerlach, K Double, P Riederer, et al.
Journal of Neural Transmission. Supplementum
|
April 24, 2007
Antioxidant capacity in postmortem brain tissues of Parkinson's and Alzheimer's diseases
E Sofic, A Sapcanin, I Tahirovic, et al.
Wiener Medizinische Wochenschrift (1946)
|
January 1, 1991
[Alzheimer dementia. A clinical long-term study with quantitative neuropathology]
P Fischer, H Lassmann, K Jellinger, et al.
Journal of Neurochemistry
|
February 1, 1989
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
P Riederer, E Sofic, W D Rausch, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 1, 1996
Creutzfeldt-Jakob disease in Austria
J A Hainfellner, K Jellinger, H Diringer, et al.
Brain Pathology (Zurich, Switzerland)
|
March 5, 2004
Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions
R Höftberger, F Aboul-Enein, W Brueck, et al.
Acta Neuropathologica
|
January 1, 1994
Amygdala pathology in Parkinson's disease
H Braak, E Braak, D Yilmazer, et al.
Neurobiology of Aging
|
July 1, 1996
On the relationship between measles virus and Alzheimer neurofibrillary tangles in subacute sclerosing panencephalitis
C Bancher, H Leitner, K Jellinger, et al.
Page
of 37
Search research articles
Search
Showing results (311-320 of 364) with videos related to
Sort By:
Page
of 37
Wiener Klinische Wochenschrift
|
December 13, 1996
[Creutzfeldt-Jakob disease in Austria]
J A Hainfellner, K Jellinger, H Diringer, et al.
Advances in Neurology
|
January 1, 1983
Combination treatment with selective monoamine oxidase inhibitors and dopaminergic agonists in Parkinson's disease: biochemical and clinical observations
P Riederer, K Jellinger, W Danielczyk, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 1, 1997
Iron in the Parkinsonian substantia nigra
M Gerlach, K Double, P Riederer, et al.
Journal of Neural Transmission. Supplementum
|
April 24, 2007
Antioxidant capacity in postmortem brain tissues of Parkinson's and Alzheimer's diseases
E Sofic, A Sapcanin, I Tahirovic, et al.
Wiener Medizinische Wochenschrift (1946)
|
January 1, 1991
[Alzheimer dementia. A clinical long-term study with quantitative neuropathology]
P Fischer, H Lassmann, K Jellinger, et al.
Journal of Neurochemistry
|
February 1, 1989
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
P Riederer, E Sofic, W D Rausch, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 1, 1996
Creutzfeldt-Jakob disease in Austria
J A Hainfellner, K Jellinger, H Diringer, et al.
Brain Pathology (Zurich, Switzerland)
|
March 5, 2004
Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions
R Höftberger, F Aboul-Enein, W Brueck, et al.
Acta Neuropathologica
|
January 1, 1994
Amygdala pathology in Parkinson's disease
H Braak, E Braak, D Yilmazer, et al.
Neurobiology of Aging
|
July 1, 1996
On the relationship between measles virus and Alzheimer neurofibrillary tangles in subacute sclerosing panencephalitis
C Bancher, H Leitner, K Jellinger, et al.
Page
of 37